Soru

Zorluk: ZorNormal Pregnancy and Prenatal Care

Match each clinical presentation during routine prenatal care with its most appropriate next step in management based on standard obstetric protocols.

  • At 28 weeks gestation, a 27-year-old O-negative patient (second pregnancy, one prior delivery) presents with an anti-D antibody titer of 1:32.Withhold anti-D immune globulin and initiate serial monitoring of fetal middle cerebral artery peak systolic velocity.
  • An asymptomatic Group B Streptococcus bacteriuria was treated at 12 weeks gestation in a 25-year-old primigravida, who is now presenting for her 36-week evaluation.Forego third-trimester rectovaginal swab screening and plan for intrapartum antibiotic prophylaxis.
  • During a 16-week prenatal visit, a 31-year-old patient (G3P2) is noted to have a maternal serum alpha-fetoprotein result of 3.2 multiples of the median.Perform a targeted fetal anatomy ultrasound to evaluate for neural tube and abdominal wall defects.
  • Following a 50-g glucose challenge test at 26 weeks gestation, a 32-year-old nulliparous patient receives a plasma glucose result of 158 mg/dL.Proceed to a 3-hour 100-g oral glucose tolerance test for definitive diagnosis.
  • Ultrasound assessment at 11 weeks for a 29-year-old pregnant patient reveals a notably enlarged fetal nuchal translucency of 3.8 mm.Offer diagnostic genetic testing via chorionic villus sampling or amniocentesis.

Cevap

The correct matches align each specific screening abnormality with its next indicated step: Rh sensitization requires monitoring fetal MCA Doppler rather than administering RhoGAM; GBS bacteriuria mandates intrapartum prophylaxis without late screening; elevated MSAFP requires a targeted anatomy ultrasound; a positive 1-hour glucose screen requires a 3-hour glucose tolerance test; and an enlarged nuchal translucency warrants offering invasive diagnostic genetic testing.
Each correct pair directly reflects evidence-based guidelines for prenatal care, successfully matching a specific maternal or fetal screening result with the standardized next clinical step to confirm a diagnosis, monitor for complications, or provide prophylaxis.

Adım Adım Çözüm

1
Evaluate the Rh status and antibody titer.
The titer of 1:32 indicates established alloimmunization (threshold is >1:16).
Recognizing established alloimmunization prevents inappropriate administration of RhoGAM and directs management toward monitoring for fetal anemia.
2
Analyze the history of GBS bacteriuria.
GBS bacteriuria early in pregnancy guarantees intrapartum prophylaxis.
Heavy colonization early in pregnancy predicts heavy colonization at delivery, so third-trimester screening is bypassed in favor of empiric treatment.
3
Assess the MSAFP elevation.
MSAFP > 2.5 MoM is abnormal and requires structural evaluation.
High alpha-fetoprotein levels are strongly associated with neural tube defects, which are best evaluated next via a comprehensive ultrasound.
4
Interpret the 1-hour glucose challenge result.
A value of 158 mg/dL is abnormal but below the direct diagnostic threshold (>200 mg/dL).
Standard two-step screening protocols require a 3-hour glucose tolerance test to confirm gestational diabetes after a positive 1-hour challenge.
5
Determine the management for an enlarged nuchal translucency.
An NT of 3.8 mm is a structural anomaly requiring diagnostic testing.
While non-invasive screening exists, significant structural findings warrant direct invasive testing (CVS/amniocentesis) for comprehensive microarray analysis.

Anahtar Kavram

Standard obstetric protocols dictate specific next steps for abnormal routine prenatal screening tests across all trimesters, focusing on distinguishing between when further screening versus definitive diagnosis or intervention is required.
Bu soruyu puanla